Consumer healthcare sales dip at GSK in 2014

GlaxoSmithKline GSK

GlaxoSmithKline’s (GSK) consumer healthcare revenues dipped by 1% last year as the global pharma giant struggled to overcome supply chain problems in the US and Europe.

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now